Literature DB >> 2068892

Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand.

P Bang1, U Eriksson, V Sara, I L Wivall, K Hall.   

Abstract

Insulin-like growth factor binding proteins interfere in the IGF-I and -II radioimmunoassays. In an attempt to overcome this problem, we have compared the use of truncated IGF-I, with reduced IGFBP affinity, and IGF-I as radioligands for IGF-I RIA measurements in serum separated by acid gel filtration or acid ethanol extraction followed by cryo-precipitation. With truncated IGF-I as radioligand the IGF-I measurements in acid gel filtrates and acid ethanol extracts were significantly correlated in healthy subjects (N = 42, r = 0.91, p less than 0.001) and in patients with acromegaly (N = 10, r = 0.85, p less than 0.01), GH deficiency (N = 10, r = 0.88, p less than 0.001) or Type I diabetes mellitus (N = 10, r = 0.90, p less than 0.001). In contrast, the IGF-I concentrations in acid ethanol extracts determined with IGF-I as radioligand did not correlate with those in acid gel filtrates using truncated IGF-I radioligand in patients with acromegaly (r = 0.61, NS) or GH deficiency (r = 0.46, NS). In the latter group the mean IGF-I concentrations measured in acid ethanol extracts were erroneously elevated by 112%. Low-affinity antibodies used for IGF-II RIA determinations failed to give reliable results in acid ethanol extracts from patients with Type I diabetes mellitus or GH deficiency. In conclusion, erroneously high IGF-I concentrations owing to binding of the radioligand to IGFBPs not completely removed by acid ethanol extraction can be avoided by the use of truncated IGF-I as radioligand.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2068892     DOI: 10.1530/acta.0.1240620

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  46 in total

1.  Long-term GH treatment of GH-deficient adults: comparison between one and two daily injections.

Authors:  C Höybye; M Rudling
Journal:  J Endocrinol Invest       Date:  2006-12       Impact factor: 4.256

2.  Insulin-like growth factor I response during nutritional rehabilitation of persistent diarrhoea.

Authors:  Z A Bhutta; P Bang; E Karlsson; L Hagenäs; S Q Nizami; O Söder
Journal:  Arch Dis Child       Date:  1999-05       Impact factor: 3.791

3.  Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy.

Authors:  Katarina Berinder; Thomas Nyström; Charlotte Höybye; Kerstin Hall; Anna-Lena Hulting
Journal:  Pituitary       Date:  2011-09       Impact factor: 4.107

4.  Dose requirement and prolactin elevation of antipsychotics in male and female patients with schizophrenia or related psychoses.

Authors:  K I Melkersson; A L Hulting; A J Rane
Journal:  Br J Clin Pharmacol       Date:  2001-04       Impact factor: 4.335

5.  Growth hormone treatment in young children with Down's syndrome: effects on growth and psychomotor development.

Authors:  G Annerén; T Tuvemo; C Carlsson-Skwirut; T Lönnerholm; P Bang; V R Sara; J Gustafsson
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

6.  Hunger-satiety signals in patients with Graves' thyrotoxicosis before, during, and after long-term pharmacological treatment.

Authors:  Sven Röjdmark; Jan Calissendorff; Olle Danielsson; Kerstin Brismar
Journal:  Endocrine       Date:  2005-06       Impact factor: 3.633

7.  Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 months.

Authors:  Inga-Lill Engvall; Birgitta Tengstrand; Kerstin Brismar; Ingiäld Hafström
Journal:  Arthritis Res Ther       Date:  2010-10-21       Impact factor: 5.156

8.  [Reduced incidence of side-effects of growth hormone substitution in 404 patients with hypophyseal insufficiency. Results of a multicenter indications study].

Authors:  C Wüster; U Melchinger; T Eversmann; J Hensen; P Kann; A von zur Mühlen; M B Ranke; H Schmeil; H Steinkamp; U Tuschy
Journal:  Med Klin (Munich)       Date:  1998-10-15

9.  Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses.

Authors:  K I Melkersson; M-L Dahl
Journal:  Psychopharmacology (Berl)       Date:  2003-07-08       Impact factor: 4.530

10.  Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients.

Authors:  K S Nair; G C Ford; K Ekberg; E Fernqvist-Forbes; J Wahren
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.